FDA & CDC Recommend Pause in Johnson & Johnson (J&J) Vaccinations
THE FDA & CDC have recommended a pause in administering J&J (Janssen) COVID vaccinations after the VAERS (Vaccine Adverse Event Reporting System) had reports of six (6) women, between the ages of 18 and 48, developing a rare type of blood clot between 6 & 13 days after receiving the J&J vaccine. This article contains an overview of the HAN Alert Recommendation and why it is so important, some information about this rare clot, adenovirus- vector COVID vaccines, a chart...
